Takeda Pharmaceutical (4502.T) Financial Statements
Price: $4540
Market Cap: $7.20T
Avg Volume: 4.11M
Market Cap: $7.20T
Avg Volume: 4.11M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Takeda Pharmaceutical.
Income Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.26T | $4.03T | $3.57T | $3.20T | $3.29T | $2.10T | $1.77T | $1.73T | $1.81T | $1.78T |
| Cost of Revenue | $1.43T | $1.24T | $1.11T | $994.31B | $1.09T | $659.69B | $495.92B | $558.75B | $535.40B | $520.99B |
| Gross Profit | $2.83T | $2.78T | $2.46T | $2.20T | $2.20T | $1.44T | $1.27T | $1.17T | $1.27T | $1.26T |
| Gross Profit Ratio | 66.43% | 69.11% | 69.00% | 68.91% | 66.89% | 68.54% | 71.99% | 67.74% | 70.38% | 70.70% |
| Research and Development Expenses | $729.92B | $633.33B | $526.09B | $455.83B | $492.38B | $368.30B | $325.44B | $312.30B | $345.93B | $382.10B |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $499.40B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $113.21B |
| Selling General and Administrative Expenses | $1.05T | $997.31B | $886.36B | $875.66B | $964.74B | $717.60B | $628.11B | $619.06B | $650.77B | $612.61B |
| Other Expenses | $834.44B | $-9.47B | $588.87B | $1.41T | $1.43T | $908.87B | $707.38B | $705.13B | $795.22B | $1.00T |
| Operating Expenses | $2.62T | $2.29T | $2.00T | $1.69T | $2.10T | $1.28T | $1.03T | $1.02T | $1.14T | $1.39T |
| Cost and Expenses | $4.05T | $3.54T | $3.11T | $2.69T | $3.19T | $1.94T | $1.53T | $1.58T | $1.68T | $1.91T |
| Interest Income | $11.29B | $62.91B | $23.70B | $105.52B | $27.83B | $6.62B | $39.54B | $12.27B | $21.64B | $15.36B |
| Interest Expense | $153.63B | $169.70B | $166.61B | $248.63B | $165.01B | $48.16B | $31.93B | $23.25B | $31.93B | $32.88B |
| Depreciation and Amortization | $728.00B | $664.40B | $583.15B | $559.67B | $583.65B | $247.69B | $182.13B | $171.43B | $197.38B | $260.95B |
| EBITDA | $874.60B | $1.18T | $1.18T | $983.72B | $880.33B | $464.22B | $359.96B | $296.88B | $349.85B | $57.29B |
| EBITDA Ratio | 20.51% | 30.02% | 29.49% | 36.73% | 20.90% | 17.95% | 24.36% | 22.48% | 19.36% | 8.35% |
| Operating Income | $214.07B | $490.50B | $460.84B | $509.27B | $100.41B | $204.97B | $241.79B | $155.87B | $130.83B | $-129.25B |
| Operating Income Ratio | 5.02% | 12.18% | 12.91% | 15.93% | 3.05% | 9.77% | 13.66% | 9.00% | 7.24% | -7.27% |
| Total Other Income Expenses Net | $-161.28B | $-115.42B | $-158.27B | $-143.03B | $-161.16B | $-110.07B | $-24.58B | $-12.52B | $-10.29B | $-16.18B |
| Income Before Tax | $52.79B | $375.09B | $302.57B | $366.24B | $-60.75B | $94.90B | $217.21B | $143.35B | $120.54B | $-145.44B |
| Income Before Tax Ratio | 1.24% | 9.31% | 8.48% | 11.45% | -1.85% | 4.52% | 12.27% | 8.28% | 6.67% | -8.18% |
| Income Tax Expense | $-91.41B | $58.05B | $72.41B | $-9.94B | $-105.04B | $-14.12B | $30.50B | $27.83B | $37.06B | $-2.40B |
| Net Income | $144.07B | $317.02B | $230.06B | $376.00B | $44.24B | $109.13B | $186.89B | $114.94B | $80.17B | $-145.78B |
| Net Income Ratio | 3.38% | 7.87% | 6.45% | 11.76% | 1.34% | 5.20% | 10.56% | 6.64% | 4.44% | -8.20% |
| EPS | $92.09 | $204.29 | $147.14 | $240.72 | $28.41 | $69.57 | $239.35 | $147.15 | $102.26 | $-92.94 |
| EPS Diluted | $91.16 | $201.94 | $145.87 | $238.96 | $28.25 | $69.57 | $237.55 | $146.26 | $101.71 | $-92.94 |
| Weighted Average Shares Outstanding | 1.56B | 1.55B | 1.56B | 1.56B | 1.56B | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B |
| Weighted Average Shares Outstanding Diluted | 1.58B | 1.57B | 1.58B | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B | 1.57B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $457.80B | $533.53B | $849.70B | $966.22B | $637.61B | $702.09B | $294.52B | $319.45B | $451.43B | $652.15B |
| Short Term Investments | $15.09B | $20.17B | $25.30B | $36.60B | $15.82B | $23.28B | $80.65B | $56.68B | $108.60B | $61.27B |
| Cash and Short Term Investments | $457.80B | $553.70B | $875.00B | $1.00T | $653.44B | $725.37B | $375.17B | $376.14B | $560.03B | $713.42B |
| Net Receivables | $697.61B | $681.69B | $724.38B | $812.71B | $784.92B | $749.12B | $428.79B | $444.78B | $430.57B | $466.83B |
| Inventory | $1.21T | $986.46B | $853.17B | $753.88B | $759.60B | $986.74B | $212.94B | $226.29B | $254.01B | $262.35B |
| Other Current Assets | $193.30B | $196.28B | $166.40B | $180.08B | $287.30B | $622.15B | $61.90B | $213.45B | $129.18B | $77.47B |
| Total Current Assets | $2.56T | $2.40T | $2.59T | $2.71T | $2.47T | $3.05T | $1.08T | $1.26T | $1.37T | $1.52T |
| Property Plant Equipment Net | $1.99T | $1.69T | $1.58T | $1.45T | $1.39T | $1.32T | $536.80B | $530.15B | $551.92B | $526.16B |
| Goodwill | $5.41T | $4.79T | $4.41T | $4.03T | $4.01T | $4.16T | $1.03T | $1.02T | $779.32B | $821.91B |
| Intangible Assets | $4.27T | $4.27T | $3.82T | $3.91T | $4.17T | $4.86T | $1.01T | $1.07T | $743.13B | $939.38B |
| Goodwill and Intangible Assets | $9.68T | $9.06T | $8.23T | $7.94T | $8.18T | $9.02T | $2.04T | $2.09T | $1.52T | $1.76T |
| Long Term Investments | $430.61B | $378.86B | $330.13B | $348.35B | $369.45B | $306.90B | $304.38B | $303.05B | $159.56B | $251.75B |
| Tax Assets | $393.87B | $366.00B | $362.54B | $353.77B | $308.10B | $88.99B | $64.98B | $118.97B | $170.77B | $154.51B |
| Other Non-Current Assets | $51.21B | $63.33B | $82.61B | $100.34B | $103.85B | $87.47B | $77.98B | $54.41B | $45.60B | $82.41B |
| Total Non-Current Assets | $12.55T | $11.56T | $10.58T | $10.20T | $10.35T | $10.82T | $3.03T | $3.10T | $2.45T | $2.78T |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $-2.00M | $- | $2.00M |
| Total Assets | $15.11T | $13.96T | $13.18T | $12.91T | $12.82T | $13.87T | $4.11T | $4.36T | $3.82T | $4.30T |
| Account Payables | $319.95B | $307.45B | $295.93B | $232.10B | $211.63B | $212.35B | $133.71B | $54.88B | $92.07B | $83.29B |
| Short Term Debt | $367.25B | $399.22B | $257.87B | $72.34B | $627.90B | $987.09B | $2.15B | $547.14B | $231.82B | $103.25B |
| Tax Payables | $109.91B | $232.38B | $200.92B | $145.20B | $182.74B | $119.48B | $67.69B | $70.58B | $43.13B | $41.07B |
| Deferred Revenue | $- | $740.74B | $644.42B | $616.48B | $587.98B | $627.26B | $200.47B | $206.38B | $158.47B | $459.66B |
| Other Current Liabilities | $1.52T | $1.54T | $1.39T | $1.32T | $1.15T | $1.23T | $533.97B | $693.75B | $490.18B | $789.21B |
| Total Current Liabilities | $2.31T | $2.48T | $2.15T | $1.77T | $2.18T | $2.51T | $737.51B | $1.37T | $857.21B | $1.02T |
| Long Term Debt | $5.03T | $4.46T | $4.55T | $5.00T | $4.83T | $4.94T | $1.04T | $656.56B | $590.38B | $645.57B |
| Deferred Revenue Non-Current | $- | $208.12B | $219.68B | $231.29B | $249.15B | $253.78B | $115.65B | $116.49B | $119.29B | $138.76B |
| Deferred Tax Liabilities Non-Current | $113.78B | $270.62B | $451.51B | $542.85B | $710.15B | $867.06B | $90.72B | $165.16B | $123.47B | $156.13B |
| Other Non-Current Liabilities | $377.98B | $179.93B | $124.80B | $188.35B | $123.55B | $1.11T | $108.50B | $374.92B | $122.53B | $132.72B |
| Total Non-Current Liabilities | $5.52T | $5.12T | $5.35T | $5.96T | $5.92T | $6.20T | $1.35T | $1.04T | $955.67B | $1.07T |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $7.83T | $7.60T | $7.49T | $7.74T | $8.09T | $8.71T | $2.09T | $2.41T | $1.81T | $2.09T |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $1.68T | $1.68T | $1.68T | $1.67T | $1.67T | $1.64T | $168.65B | $140.18B | $133.59B | $123.62B |
| Retained Earnings | $1.39T | $1.54T | $1.48T | $1.51T | $1.37T | $1.57T | $1.56T | $1.51T | $1.52T | $1.60T |
| Accumulated Other Comprehensive Income Loss | $2.51T | $1.51T | $934.17B | $366.11B | $92.56B | $349.88B | $-4.79B | $291.00B | $327.94B | $430.31B |
| Other Total Stockholders Equity | $1.70T | $1.63T | $1.59T | $1.63T | $1.59T | $1.59T | $16.37B | $26.24B | $32.85B | $41.37B |
| Total Stockholders Equity | $7.27T | $6.35T | $5.68T | $5.17T | $4.72T | $5.16T | $2.00T | $1.89T | $1.95T | $2.14T |
| Total Equity | $7.27T | $6.35T | $5.68T | $5.18T | $4.73T | $5.16T | $2.02T | $1.95T | $2.01T | $2.21T |
| Total Liabilities and Stockholders Equity | $15.11T | $13.96T | $13.18T | $12.91T | $12.82T | $13.87T | $4.11T | $4.36T | $3.82T | $4.30T |
| Minority Interest | $741.00M | $549.00M | $504.00M | $4.14B | $4.00B | $4.01B | $19.98B | $54.70B | $62.51B | $69.13B |
| Total Liabilities and Total Equity | $15.11T | $13.96T | $13.18T | $12.91T | $12.82T | $13.87T | $4.11T | $4.36T | $3.82T | $4.30T |
| Total Investments | $445.70B | $99.17B | $96.58B | $112.47B | $107.33B | $108.19B | $385.03B | $359.73B | $268.16B | $313.02B |
| Total Debt | $4.84T | $4.38T | $4.35T | $4.64T | $5.09T | $5.75T | $985.66B | $1.14T | $768.22B | $729.38B |
| Net Debt | $4.39T | $3.85T | $3.50T | $3.67T | $4.46T | $5.05T | $691.14B | $825.43B | $316.80B | $77.23B |
Cash Flow Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $144.07B | $317.04B | $230.17B | $376.17B | $44.29B | $109.01B | $186.71B | $115.51B | $83.48B | $-143.03B |
| Depreciation and Amortization | $728.00B | $664.40B | $583.15B | $559.67B | $583.65B | $272.45B | $182.13B | $222.79B | $197.38B | $260.95B |
| Deferred Income Tax | $-91.41B | $58.05B | $72.41B | $-9.94B | $-105.04B | $-14.12B | $30.50B | $27.83B | $37.06B | $-2.40B |
| Stock Based Compensation | $70.87B | $60.67B | $43.37B | $37.66B | $29.12B | $20.08B | $18.61B | $17.41B | $14.71B | $20.35B |
| Change in Working Capital | $-256.00B | $-25.26B | $98.61B | $275.78B | $94.67B | $75.95B | $13.40B | $29.68B | $-267.21B | $262.33B |
| Accounts Receivables | $15.10B | $75.13B | $127.29B | $-9.32B | $-34.83B | $-13.38B | $-647.00M | $-37.31B | $12.37B | $-32.52B |
| Inventory | $-115.74B | $-79.16B | $-46.15B | $25.98B | $137.49B | $58.68B | $13.72B | $3.89B | $-6.84B | $-14.55B |
| Accounts Payables | $-9.89B | $-53.13B | $75.55B | $210.02B | $-29.93B | $-16.41B | $6.86B | $42.56B | $17.91B | $-7.08B |
| Other Working Capital | $-145.47B | $31.90B | $-58.09B | $49.10B | $21.94B | $47.06B | $-6.53B | $20.55B | $-290.65B | $316.47B |
| Other Non Cash Items | $120.81B | $-97.74B | $95.40B | $-228.42B | $23.06B | $-134.89B | $-53.49B | $25.49B | $22.10B | $-80.02B |
| Net Cash Provided by Operating Activities | $716.34B | $977.16B | $1.12T | $1.01T | $669.75B | $328.48B | $377.85B | $261.36B | $25.49B | $182.52B |
| Investments in Property Plant and Equipment | $-175.42B | $-633.69B | $-186.04B | $-236.47B | $-217.71B | $-134.11B | $-128.26B | $-112.03B | $-84.86B | $-108.72B |
| Acquisitions Net | $-4.74B | $7.96B | $-21.48B | $530.39B | $456.66B | $-2.87T | $56.75B | $-524.74B | $-7.05B | $-20.43B |
| Purchases of Investments | $-40.07B | $-10.15B | $-8.34B | $-12.60B | $-7.55B | $-17.10B | $-88.66B | $-82.11B | $-40.02B | $-3.57B |
| Sales Maturities of Investments | $8.02B | $22.25B | $16.92B | $74.60B | $49.40B | $65.03B | $40.74B | $75.27B | $56.45B | $165.36B |
| Other Investing Activities | $-251.66B | $6.53B | $808.00M | $37.60B | $11.32B | $124.03B | $26.08B | $-12.09B | $4.26B | $58.71B |
| Net Cash Used for Investing Activities | $-463.86B | $-607.10B | $-198.12B | $393.53B | $292.12B | $-2.84T | $-93.34B | $-655.69B | $-71.21B | $91.35B |
| Debt Repayment | $1.51B | $-325.07B | $-600.48B | $-656.06B | $-586.09B | $3.16T | $-153.14B | $471.42B | $45.92B | $-119.50B |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-2.33B | $-26.93B | $-77.53B | $-2.14B | $-3.74B | $-1.17B | $-18.76B | $-23.12B | $-22.35B | $-17.59B |
| Dividends Paid | $-287.19B | $-279.42B | $-283.67B | $-283.36B | $-282.58B | $-142.95B | $-141.89B | $-141.69B | $-141.54B | $-141.64B |
| Other Financing Activities | $-66.42B | $-77.73B | $-108.59B | $-146.79B | $-132.80B | $-71.14B | $-12.44B | $-16.72B | $-6.88B | $-22.27B |
| Net Cash Used Provided by Financing Activities | $-354.42B | $-709.15B | $-1.07T | $-1.09T | $-1.01T | $2.95T | $-326.23B | $289.90B | $-124.84B | $-301.00B |
| Effect of Forex Changes on Cash | $26.20B | $22.93B | $28.76B | $12.50B | $-21.77B | $-31.27B | $-4.57B | $-5.74B | $-33.26B | $16.33B |
| Net Change in Cash | $-75.73B | $-316.17B | $-116.53B | $328.61B | $-65.11B | $407.12B | $-46.73B | $-131.97B | $-203.82B | $-10.80B |
| Cash at End of Period | $457.80B | $533.53B | $849.70B | $966.22B | $637.61B | $702.09B | $294.52B | $319.45B | $451.43B | $655.24B |
| Cash at Beginning of Period | $533.53B | $849.70B | $966.22B | $637.61B | $702.72B | $294.97B | $341.25B | $451.43B | $655.24B | $666.05B |
| Operating Cash Flow | $716.34B | $977.16B | $1.12T | $1.01T | $669.75B | $328.48B | $377.85B | $261.36B | $25.49B | $182.52B |
| Capital Expenditure | $-480.73B | $-633.69B | $-186.04B | $-236.47B | $-217.71B | $-134.11B | $-128.26B | $-112.03B | $-84.86B | $-108.72B |
| Free Cash Flow | $235.61B | $343.47B | $937.07B | $774.46B | $452.04B | $194.37B | $249.59B | $149.34B | $-59.37B | $73.80B |